Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Current Assets (2016 - 2021)

Historic Current Assets for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $14.5 million.

  • ENDRA Life Sciences' Current Assets rose 20275.38% to $14.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was $14.5 million, marking a year-over-year increase of 20275.38%. This contributed to the annual value of $8.2 million for FY2020, which is 2559.47% up from last year.
  • ENDRA Life Sciences' Current Assets amounted to $14.5 million in Q3 2021, which was up 20275.38% from $16.3 million recorded in Q2 2021.
  • ENDRA Life Sciences' Current Assets' 5-year high stood at $18.4 million during Q1 2021, with a 5-year trough of $265648.0 in Q1 2017.
  • For the 5-year period, ENDRA Life Sciences' Current Assets averaged around $6.3 million, with its median value being $4.8 million (2020).
  • Per our database at Business Quant, ENDRA Life Sciences' Current Assets surged by 290734.33% in 2017 and then tumbled by 8617.42% in 2018.
  • Over the past 5 years, ENDRA Life Sciences' Current Assets (Quarter) stood at $5.9 million in 2017, then rose by 18.15% to $6.9 million in 2018, then decreased by 5.96% to $6.5 million in 2019, then grew by 25.59% to $8.2 million in 2020, then soared by 76.3% to $14.5 million in 2021.
  • Its Current Assets was $14.5 million in Q3 2021, compared to $16.3 million in Q2 2021 and $18.4 million in Q1 2021.